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Abstract
Athanassiadis M, Jacobsen N, Parashos P. The effect of
calcium hydroxide on the steroid component of Ledermix
  and
Odontopaste
 . International Endodontic Journal, 44, 1162–1169,
2011.
Aim To investigate the chemical interaction of cal-
cium hydroxide with the corticosteroid triamcinolone
acetonide in Ledermix
  Paste and in Odontopaste
 ,a
new steroid/antibiotic paste.
Methodology Validated methods were developed to
analyse the interaction of calcium hydroxide in
two forms, Pulpdent
  Paste and calcium hydroxide
powder, with triamcinolone acetonide within Odonto-
paste
  and Ledermix
  Paste. High-performance liquid
chromatography (HPLC) was used to analyse the mixed
samples of the pastes and calcium hydroxide. The
concentration of triamcinolone acetonide within the
pastes was determined over 0, 2, 6, 24 and 72-h time-
points. All tests with the HPLC involved the testing of
the standard with triplicate injections alongside the
samples. All samples were tested in duplicate with each
injected twice; therefore, four tests were performed for
each investigation. Linearity, precision and speciﬁcity
of the testing procedures and apparatus were validated.
Descriptive statistics are provided.
Results In both pastes, there was a marked rapid
destruction of the triamcinolone acetonide steroid upon
mixing with calcium hydroxide. Odontopaste
  suffered
a lower rate of destruction of the triamcinolone
acetonide component than Ledermix
  Paste, but both
pastes showed very similar degrees of steroid destruc-
tion after 72 h. When using calcium hydroxide powder
with Ledermix
  Paste, the triamcinolone was destroyed
entirely and immediately.
Conclusion The addition of calcium hydroxide to
Odontopaste
  or Ledermix
  Paste results in the rapid
destruction of the steroid.
Keywords: calcium hydroxide, Ledermix Paste,
Odontopaste, triamcinolone acetonide.
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Introduction
Calcium hydroxide paste is a root canal medicament
that has been used in endodontics for many years. It
exhibits antibacterial properties and has the ability to
stimulate hard tissue repair within bone and cementum
(Heithersay 1975, Tronstad et al. 1981). Ledermix
 
Paste (Haupt Pharma GmbH, Wolfratshausen, Ger-
many) has been recommended for endodontic use
owing to its anti-inﬂammatory effect (Ehrmann 1981).
Odontopaste
  (Australian Dental Manufacturing, Ken-
more Hills, Qld, Australia) has recently been released
onto the dental market, similarly for its anti-inﬂamma-
tory effect. The main difference between Odontopaste
 
and Ledermix
  Paste is that clindamycin hydrochloride
in Odontopaste
  replaces demeclocycline hydrochloride
in Ledermix
  Paste. Clindamycin hydrochloride has an
equivalent spectrum of antibacterial activity but exhib-
its minimal staining of teeth (Adamidou 2010).
Calcium hydroxide and the two steroid/antibiotic
pastes serve different purposes, so in an effort to obtain
the beneﬁts of both, a 50 : 50 mix of calcium hydroxide
and Ledermix Paste has been recommended (Abbott
et al. 1989, Taylor et al. 1989). This early research was
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acetonide and liquid scintillation counters to detect the
beta decay of tritium, which correlates the counts with
a concentration of the tritium-labelled component
(Abbott et al. 1989). However, the exact nature of the
molecule labelled by the tritium is not known because
there are a possible 31 positions for the tritium-labelled
hydrogen on a molecule of triamcinolone acetonide,
and previous research has not identiﬁed whether the
scintillation counter was measuring the labelled steroid
or a breakdown product. Triamcinolone acetonide is
also polymorphic. British Pharmacopoeia (BP) and
United States Pharmacopeia (USP) grades of triamcin-
olone acetonide conform to a particular type of the
possible polymorphic forms, and the manufacturing
process can control which polymorphic form is pro-
duced. Whether this remains the case with the tritium-
labelled triamcinolone acetonide is unknown. Previous
studies have found varying degrees of breakdown of
steroids at high pH (Dekker & Buijs 1980, Hansen &
Bundgaard 1980, Ogata et al. 1998, Spangler & Mularz
2001, Conrow et al. 2002, Teng et al. 2003, Nygaard
et al. 2004, Go ¨ro ¨g 2010), so it is conceivable that the
tritium labelling may not be on an active molecule, but
may be on a breakdown product.
Therefore, this study was undertaken to investigate
the effects of the addition of calcium hydroxide in the
form of calcium hydroxide powder and in the form of
Pulpdent
  Paste (Pulpdent Corporation, Watertown,
MA, USA) on the stability of the steroid component of
two endodontic pastes, Odontopaste
  (Australian Den-
tal Manufacturing) and Ledermix
  (Haupt Pharma
GmbH).
Materials and methods
The two pastes along with the other products utilized in
this research project are summarized in Table 1. All
tests were carried out independently by an external
laboratory licensed by the Australian Therapeutic
Goods Administration (TGA) and with Good Laboratory
Practice certiﬁcation. All batches were tested in com-
pliance with manufacturers’ claims prior to testing.
Method validation for Triamcinolone Acetonide in
Odontopaste
 /Ledermix
 
The method for detecting triamcinolone acetonide was
validated for each paste. High-performance liquid
chromatography (HPLC) was used to analyse the mixed
samples of paste and calcium hydroxide. The validation
parameters that were measured and the assessment of
the results were chosen so as to conform to the
following protocols:
• The International Conference on Harmonisation of
Technical Requirements for Registration of Pharma-
ceuticals for Human Use (ICH) – Validation of Analyt-
ical Procedures: Text and Methodology as adopted by
the TGA, Australia (European Medicines Agency
2006),
• Guidelines for the Validation and Veriﬁcation of
Chemical Test Methods. National Association of Testing
Authorities, NATA Technical Note 17 (NATA 2009).
• Guidelines for the Validation of Analytical Methods
for Active Constituents, Agricultural and Veterinary
Chemical Products October 2004 (APVMA 2004),
Where no acceptance criteria existed other recog-
nized sources were used, predominantly, the Associa-
tion of Analytical Communities-Single Laboratory
Validation Acceptance Criteria (AOAC 2009).
For all analyses, all pH readings were taken utilizing a
Mettler Toledo 7s calibrated pH metre (Mettler Toledo,
Aurora, IL, USA). A Varian ProStar (Agilent Technol-
ogies, Palo Alto, CA, USA) with ternary gradient pump
and programmable single channel UV detector was
used. The columns consisted of Allsphere ODS-2 (All-
Table 1 A comparison of the materials used and their respective ingredients
Ingredient
(%w/w) Odontopaste
  Ledermix
  Pulpdent
 
Calcium hydroxide
powder BP grade
Clindamycin hydrochloride 5% – – –
Demeclocycline hydrochloride
(calcium salt)
–3 % – –
Triamcinolone acetonide 1% 1% – –
Base paste incipient
ingredients
Equivalent Equivalent – –
Puriﬁed water Present Present Present –
Calcium hydroxide Present – 40% >98%
Methyl cellulose – – Present –
BP, British pharmacopoeia.
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The column guards were Phenomenex Security Guard
C18 inserts (Torrance, CA, USA). The data were
collected using Varian Star software. The reference
standard for triamcinolone acetonide was obtained from
Sigma-Aldrich (St. Louis, MO, USA). The reagents used
were a mixture of methanol (HPLC grade), water and
glacial acetic acid. Operating conditions were as follows:
ﬂow rate was 1.2 mL min
)1, equilibrium time was ten
minutes, detector wavelength was 283 nm, the injec-
tion volume was 20 lL and the retention time was
approximately 4.6 min. Standards were prepared by
weighing 10 and 100 mg of triamcinolone acetonide
(taking into account the potency of the steroid) into
100 mL of methanol. The ﬂask was ultrasonicated until
the triamcinolone acetonide had fully dissolved. The
solution was then ﬁltered through 0.45 lm ﬁlter paper
intotheHPLCvial.The sampleswerepreparedbytaking
the well-mixed paste, which theoretically contained 10
and 100 mg of triamcinolone acetonide, and this was
added tothesolution asabove andﬁltered with0.45 lm
ﬁlter paper into the HPLC vial.
Samples were run through in duplicate, and the
calculations were made according to the following
formula:
Sample PA
Std PA
 
Wt. Std (mg)
Vol. Std (ml)
 
Std Potency (%)
100
 
Vol. Sample (ml)
Wt. Sample (g)
¼
mg
g
where PA = peak area.
Linearity (i.e. the ability within a given range to
obtain test results that are directly proportional to the
concentration of the analyte in the sample being tested)
was validated using ﬁve concentration standards of
triamcinolone acetonide (Sigma-Aldrich) with a po-
tency of 99.5%. These standards (Table 2) were anal-
ysed, and the resultant areas were used to prepare a
calibration curve (Fig. 1) that was then used to
determine the measured concentration of each of the
ﬁve calibration standards.
Precision of the testing apparatus was considered at
three levels, repeatability, intermediate precision and
reproducibility. System precision for Odontopaste
 
utilized 10.2 mg per 100 mL triamcinolone acetonide
at 99.5% potency. The standard was injected six times,
as required by the International Conference on Har-
monisation (European Medicines Agency 2006). Sys-
tem precision for Ledermix
  Paste utilized 10.2 mg per
100 mL triamcinolone acetonide at 99.4% potency.
The standard was injected six times.
The AOAC (2009) considers that for samples con-
taining 0.01% of the analyte, a repeatability of 4% is
recommended. Repeatability is measured by the rela-
tive standard deviation (RSD), and as such, the RSD of
0.17% for Odontopaste
  and 1% for Ledermix
  Paste is
considered acceptable.
Speciﬁcity (to validate that the analyte alone was
being tested, free from the effects of the matrix of other
ingredients) was performed by analysing a placebo that
is a sample containing all of the ingredients except the
active, and the analysis of the placebo spiked with the
analyte. Whilst the placebo could be considered as a
negative control, in this type of analysis, it is utilized to
determine peak purity rather than validating a method.
A placebo was prepared by ADM of Odontopaste
  and
tested. Approximately 1 g of the placebo mix was
subsampled and extracted as per the method originally
developed. An additional 1 g placebo was then sub-
sampled, and a known amount of triamcinolone
acetonide was added and then extracted according to
the method. This formed the spiked sample. In addition,
spiked samples were also tested for speciﬁcity. Interfer-
ence from the placebo was not observed, and the spike
recovery of 97.6% is within the limits of 85–110% as
recommended by the AOAC (2009). As such, the
speciﬁcity of the method was considered acceptable.
For Ledermix
  Paste, it was decided to not produce a
placebo as there may have been questions raised
concerning the accuracy of the placebo’s formulation.
Speciﬁcally, because the exact formula of Ledermix
 
Table 2 Concentration of standards used for validation of
linearity. The measured concentrations are compared to the
actual
Triamcinolone
acetonide
added (mg)
Concentration
mg per 100 mL
Average
peak area
Measured
concentration
mg per 100 mL
Odontopaste
  testing program
(Potency of the standard is 99.5%)
15.2 15.124 1 499 099 15.017
13.2 13.134 1 322 166 13.215
10.2 10.149 1 026 276 10.203
8.2 8.159 830 246 8.207
5.1 5.075 515 201 4.999
Ledermix
  Paste testing program
(Potency of the standard is 99.4%)
17.93 17.826 2 158 333 17.78
15.37 15.279 1 866 610 15.36
12.81 12.733 1 562 085 12.85
10.25 10.186 1 223 774 10.01
7.69 7.640 910 983 7.47
5.12 5.093 642 576 5.25
Calcium hydroxide effect on a steroid Athanassiadis et al.
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duce an accurate placebo would not have been
possible. It was therefore decided to extract the triam-
cinolone acetonide from a sample and a spiked sample
(i.e. 30% spike on half the sample weight so that it
remained within the linear range of the validation).
This was then analysed. The results were within the
limits recommended by the AOAC (2009), and hence,
speciﬁcity was considered acceptable.
Accuracy for Odontopaste
  was investigated by the
analysis of a number of placebo subsamples spiked with
triamcinolone acetonide. Six separated determinations
were performed. Approximately 1.0 g of placebo was
subsampled into six separate vessels. The extraction of
triamcinolone acetonide was carried out as per the
methodearlier.Theaveragerecoverywas97.6%,which
was again within the accepted range (AOAC 2009), and
considered acceptable. The accuracy testing for Leder-
mix
  Paste was investigated by analysing a number of
samples spiked with different levels of the triamcinolone
acetonide standard. Nine separate determinations were
performed, incorporating three replicate spikes at three
different concentration levels of 8 mg per 100 mL,
10 mg per 100 mL and 13 mg per 100 mL as described
in the accuracy-spiking recovery data. Duplicate injec-
tions of each spike were carried out.
A stock solution of triamcinolone acetonide standard
was prepared (104.61 mg per 100 mL triamcinolone
acetonide – potency 99.4%). Samples containing
approximately 50 ppm active were spiked at 3 mg per
100 mL, 5 mg per 100 mL and 8 mg per 100 mL of
triamcinolone acetonide standard and extracted. Each
spiked level was performed in triplicate. The levels of
spike were chosen so that the total concentrations of
active in the spikes were within the linear range of this
validation. The sample and spikes were analysed, and
the recoveries were determined individually. The per
cent recovery for the three levels of spikes meets the
acceptance criteria for a 1.0% concentration solution of
92–105% for triamcinolone acetonide.
Testing of starting materials
All tests with the HPLC involved the testing of the
standard with triplicate injections alongside the sam-
ples. Results were rejected from the test run if the
differences between the standard’s results were >3%.
All test samples were tested in duplicate with each
injected twice; therefore, four tests were performed for
each investigation. If the results for the samples tested
for each individual investigation differed by more than
3%, they were rejected. Throughout the testing, no
rejections occurred.
Odontopaste
  and Ledermix
  pastes were tested for
the initial concentration of triamcinolone acetonide.
Pulpdent
  was tested for the percentage of calcium
hydroxide present. The calcium hydroxide raw powder
was of BP grade and was tested for purity.
Testing of combinations
The following products were mixed in a 50 : 50 ratio
by weight:
Time-point analysis
• Ledermix
  Paste with Pulpdent
 
• Ledermix
  Paste with Calcium Hydroxide Powder
BP grade
• Odontopaste
  with Pulpdent
 
• Odontopaste
  with Calcium Hydroxide Powder BP
grade
Analysis at zero time-point only
• Pulpdent
  with a 1.4% triamcinolone acetonide
only paste in an aqueous paste
• Pulpdent
  with a 1.4% triamcinolone acetonide
only paste in a peg/aqueous paste
The following was also tested for concentrations of
triamcinolone acetonide:
• Odontopaste
  with 2% calcium hydroxide w/w
• Odontopaste
  with 0.5% calcium hydroxide w/w
• Calcium hydroxide powder with 2% triamcinolone
acetonide w/w
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Figure 1 Linear calibration curve for method validation. A determination for the standard deviation was made.
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mixed in a closed container for 3 min. For a large
volume of paste, there was a concern that the mixing
would not result in a homogeneous paste particularly if
clinical times of <30 s were used. Therefore, it was
decided to mix for longer than what would be
performed so clinically. Following the mixing, the
samples were then subsampled from the closed con-
tainer and placed through the HPLC to determine the
amount of triamcinolone acetonide present at differing
time-points. The time taken for the samples to be
analysed was approximately 3 min. They were then
tested for the presence of triamcinolone acetonide at 0,
6, 24 and 72 h.
The Pulpdent
  samples that were mixed 50 : 50
with custom-made 1.4% triamcinolone acetonide
pastes were tested at zero time-point only. The two
custom samples were produced to eliminate many of
the Odontopaste
  and Ledermix
  Paste ingredients,
thereby narrowing down the possible cause of the
steroid’s degradation.
The two samples of Odontopaste
  with 0.5% calcium
hydroxide and 2% calcium hydroxide were prepared
under ISO 13485:2003, a medical device quality
assurance system, and tested prior to use. The mixing
was validated to ensure no issue with the homogeneity
of the paste.
Because this work did not aim to compare the two
products, only descriptive statistics were originally
intended, but the appropriateness of statistical analysis
was to be based on the raw data.
Results
The initial testing of the ingredients resulted in the
concentrations of the key components as listed in
Tables 3–5. The time-point testing results for the
percentage of triamcinolone acetonide when Odonto-
paste
 andLedermix
 weremixedwithcalciumhydrox-
ide powder BP grade are listed in Table 6 demonstrating
rapid loss of the steroid. Similar results were obtained
with Pulpdent
  paste, although the initial and overall
destruction of the steroid in Odontopaste was less
(Table 7).RapidandextensivedestructionbyPulpdent
 
Paste of the 1.4% triamcinolone acetonide occurred also
in the custom-made pastes (Table 8). Increasing con-
centrations of calcium hydroxide demonstrated increas-
ingly destructive effect of the steroid (Table 9). Because
thedegreeofdestructionofthesteroidcomponentofboth
pastes was so similar, the need for statistical comparison
was considered superﬂuous.
Discussion
The initial testing of all the components revealed that
Pulpdent
  Paste contained 19.2% calcium hydroxide.
This was markedly and unexplainably lower than the
manufacturer’s speciﬁcation of 40%. However, it was
decided to continue the testing with this lower amount
as this may reﬂect the true clinical concentration of
Table 3 The percentage of triamcinolone acetonide and the
pH of Odontopaste
  and Ledermix
  Pastes prior to mixing
with calcium hydroxide
Product
% of triamcinolone acetonide
prior to testing pH value
Odontopaste
  1.14
a 8.5
Ledermix
  Paste 1.0 8.2
aThe use of overage accounts for the higher initial concentra-
tion.
Table 4 The percentage of calcium hydroxide in Pulpdent
 
and the BP grade of calcium hydroxide powder used prior to
the mixing of the components
Product
% (w/w) of
calcium
hydroxide pH value
Pulpdent
  19.2 12.5
Calcium hydroxide powder BP grade 98.2 –
BP, British pharmacopoeia.
Table 5 Initial testing of custom-made triamcinolone aceto-
nide pastes to validate the presence of steroid
Product
% (w/w) of
triamcinolone
acetonide
Custom-made triamcinolone
acetonide paste in aqueous only paste
1.4
Custom-made triamcinolone
acetonide paste in peg/aqueous paste
1.4
Table 6 The time-point results for triamcinolone acetonide
when powdered calcium hydroxide with 98.2% purity is mixed
with Odontopaste
  and Ledermix
  in a 50 : 50 ratio
Compound Premixing (%)
0h
(%)
1h
(%)
6h
(%)
24 h
(%)
72 h
(%)
Odontopaste
  1.14 0.09 0.07 0.03 0.01 0.03
)84 )87 )94 )98 )94
Ledermix
  1.00 0 0 0 0 0
)100 )100 )100 )100 )100
Percentage loss was calculated on 50% of premix percentages
owing to dilution with the 50 : 50 mixing. e.g. )84% = (0.09%/
(1.14%/2)) ) 100%.
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clinical environment. With less calcium hydroxide, the
effects were expected to be milder than if the Pulpdent
 
Paste had calcium hydroxide present at 40%. All the
other utilized products tested were as per the
manufacturers’ speciﬁcation. The higher initial amount
of triamcinolone acetonide in Odontopaste
  in
comparison with Ledermix
  was owing to the use of
‘overage’ in its manufacture. It is not uncommon for
manufacturers to compensate for loss of actives during
the manufacturing process or to compensate for lack of
purity of the active ingredients. This is referred to as
‘overage’ and is a percentage of the active ingredient
above the labelled amount. Odontopaste
  uses the
same process of overage for its manufacture. Hence, the
labelled amount on the packaging, in general, refers to
the amount present at the time of expiry, and the
product may contain higher amounts of the active
ingredients at the time of initial manufacture to
compensate for the loss of the same actives over time.
As a result, the inactive ingredients, more commonly
referred to as excipients, may vary from batch to batch
depending on the overage adjustments required.
The effect of calcium hydroxide on the steroid
component, triamcinolone acetonide, of both Odonto-
paste
  and Ledermix
  Pastes was considerable. It
resulted in a reduction in the triamcinolone acetonide
component in both Odontopaste
  and Ledermix
 .
There was less loss of the steroid component in
Odontopaste
  in both the calcium hydroxide powder
and Pulpdent
  Paste groups. The 24-h time-point
results showed an increase in the amount of triamcin-
olone acetonide, and this can only be explained by the
mixing not being homogeneous. These results were not
discarded and are valuable in that they show the effect
that mixing may have on the interaction of calcium
hydroxide with triamcinolone acetonide. In clinical
situations, the mixing is commonly performed within
the canal because the consistency after mixing is such
that attempting to place the mixture with a lentulo-
spiral bur or paste-ﬁller bur is very difﬁcult and
inefﬁcient.
In addition, the level at which the steroid, triamcin-
olone acetonide, is therapeutic within a root canal is
unknown. Therefore, whether or not there is any loss of
the therapeutic effect from the reduced levels of the
steroid cannot be deﬁnitively determined. A recent
study concluded that a level >1% triamcinolone
acetonide was preferred or that stronger steroids such
as dexamethasone or prednisone be utilized (Chen et al.
2008). Therefore, any loss of steroid should be of
concern.
It is clear that triamcinolone acetonide was actively
broken down by calcium hydroxide. The tests with the
custom pastes in Table 8 conﬁrm that no other
ingredients are responsible for the destruction of the
triamcinolone acetonide other than the calcium
hydroxide. Interestingly, the addition of triamcinolone
acetonide to raw calcium hydroxide powder also
resulted in the rapid destruction of the triamcinolone
acetonide (Table 9). The chemistry behind the reaction
is not fully understood. It is unlikely that degradation
occurs when the products are in powdered form. For
the breakdown to occur, an aqueous solution is
required. However, when calcium hydroxide is exposed
Table 7 The time-point results for triamcinolone acetonide
when Pulpdent
  is mixed with Odontopaste
  and Ledermix
 
in a 50 : 50 ratio
Compound
Premixing
(%)
0h
(%)
1h
(%)
6h
(%)
24 h
(%)
72 h
(%)
Odontopaste
  1.14 0.440 0.310 0.200 0.350 0.060
)20 )44 )64 )36 )89
Ledermix
  1.0 0.097 0.079 0.063 0.084 0.020
)81 )84 )87 )83 )96
Percentage loss was calculated on 50% of premix percentages
owing to dilution with the 50 : 50 mixing.
Table 8 The results for the addition of Pulpdent
  50 : 50 with
custom-made triamcinolone acetonide pastes
Compound
Premixing
(%)
Post mixing
(%)
1.4% Triamcinolone acetonide
in aqueous paste mixed with
Pulpdent
  50 : 50
1.4 0.25
1.4% Triamcinolone acetonide in
aqueous/peg paste mixed with
Pulpdent
  50 : 50
1.4 0.16
Table 9 The effect on the triamcinolone acetonide component
of Odontopaste
  with different amounts of calcium hydroxide
and the effect of dry calcium hydroxide powder when mixed
with triamcinolone acetonide
Compound
Amount of
calcium
hydroxide (%)
Triamcinolone
acetonide
added (%)
Triamcinolone
acetonide
recovered (%)
Odontopaste
  0.5 1.14 1.14
Odontopaste
  2 1.14 0.53
Calcium
hydroxide
powder
98 2 0
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calcium carbonate with the concomitant production of
water (Armstrong 2009). This water may provide a
sufﬁcient vehicle for the activity of the hydroxyl ions to
destroy the steroid. However, the amount of water
produced from this reaction is small, reducing the
likeliness of this scenario. A more probable explanation
may be the presence of an aqueous component from
the extraction media used when injecting the test
materials into the HPLC. The aqueous component may
provide the environment required for the dissociation
of the calcium hydroxide in the test sample and
therefore the formation of the hydroxyl ions, which
degrade the steroid in an oxidative reaction (Hansen &
Bundgaard 1980). This is a more plausible explanation
and would reinforce the rapid rate of degradation of
triamcinolone acetonide found in the presence of
calcium hydroxide.
These results indicate that there is no real advantage
with mixing calcium hydroxide with Ledermix
  or
Odontopaste
 . Furthermore, there is no signiﬁcant
antibacterial advantage of the combinations when
compared to calcium hydroxide alone (Plutzer 2009).
In addition, what occurs to the antibiotic by the
calcium hydroxide has not been investigated. Another
important consideration is the known issue of staining
of teeth with Ledermix
  (Kim et al. 2000, Adamidou
2010, Day et al. 2011). Staining is not clinically
signiﬁcant with Odontopaste
  and most calcium
hydroxide formulations (Adamidou 2010). Hence, if a
purely antibacterial action is required, then the use of
calcium hydroxide is sufﬁcient. If a steroid action is
required, then the use of Odontopaste
  or Ledermix
 
would seem acceptable with only Odontopaste
  not
causing the teeth to stain.
As a corollary to the results of this study, a lower
level of calcium hydroxide may be satisfactory as an
antibacterial agent. There have been no studies to
accurately indicate what percentage of calcium
hydroxide is sufﬁcient to provide an antibacterial effect
within a root canal. The 50 : 50 mixing may indicate
that 20% Pulpdent
  is just as effective as 40%
Pulpdent
  giving some insight into the therapeutic
threshold for calcium hydroxide as an antibacterial.
Conclusions
The results of this study do not validate the previous
research regarding the addition of calcium hydroxide to
Ledermix
  Paste. They do however validate research
performed on the breakdown of steroids in an alkaline
environment. The addition of calcium hydroxide in the
form of Pulpdent
  or BP grade calcium hydroxide
powder to Odontopaste
  or Ledermix
  Paste in a
50 : 50 ratio results in the rapid destruction of the
steroid, triamcinolone acetonide. Calcium hydroxide,
therefore, cannot reduce the rate of diffusion of all the
active components within the paste and would not
make the medicament last longer within the canal. It
does not assist in keeping a higher concentration of all
the components within the canal. The validity and
continued use of calcium hydroxide with Odontopaste
 
and Ledermix
  Pastes should be reconsidered, and
further testing is required to determine the breakdown
products produced.
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